Posted in English Canada Approves Amylyx’s ALS Drug; FDA To Consider Approval In September June 13, 2022 The Canadian government has given its approval to AMX0035, a new drug from Cambridge, Massachusetts-based Amylyx Pharmaceuticals Inc. https://markets.businessinsider.com/news/stocks/canada-approves-amylyx-s-als-drug-fda-to-consider-approval-in-september-1031525698